Literature DB >> 7676689

News of TNM and its use for classification of gastric cancer.

P Hermanek1, C Wittekind.   

Abstract

Tumor classification is associated with two inherent problems: (1) to find a compromise between the simplicity needed for a wide application by the medical community and sufficient differentiation and specification required for the presently high differentiation in treatment options and for detailed analysis of treatment results; and (2) to achieve an agreement between the stability necessary for data collection over long periods and the needed continuous inclusion of new proposals that arise by advances in diagnostic and therapeutic methods and the increasing knowledge of prognostic factors. The aim of this report is to inform on the changes and expansions of the international classification of gastric carcinoma during the last few years, to refer to new developments, to point out the relations between established classifications and molecular biology, and to show the future trend in tumor classification.

Entities:  

Mesh:

Year:  1995        PMID: 7676689     DOI: 10.1007/bf00294707

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Future directions for the American Joint Committee on Cancer.

Authors:  D E Henson
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

Review 2.  Molecular pathology of gastric carcinoma: progress and prospects.

Authors:  P A Wright; P Quirke; R Attanoos; G T Williams
Journal:  Hum Pathol       Date:  1992-08       Impact factor: 3.466

Review 3.  [Lymphadenectomy in stomach and colorectal carcinoma].

Authors:  J R Siewert; J Lange
Journal:  Dtsch Med Wochenschr       Date:  1990-03-09       Impact factor: 0.628

4.  The general rules for The gastric cancer study in surgery.

Authors: 
Journal:  Jpn J Surg       Date:  1973-03

5.  Prognostic grouping: the next step in tumor classification.

Authors:  P Hermanek; R V Hutter; L H Sobin
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

Review 7.  Genetic alterations in human gastric cancer.

Authors:  S Hirohashi; T Sugimura
Journal:  Cancer Cells       Date:  1991-02

8.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  [Systematic extended lymph node dissection in curative therapy of stomach cancer].

Authors:  F P Gall; P Hermanek
Journal:  Chirurg       Date:  1993-12       Impact factor: 0.955

10.  Isolation of an amplified DNA sequence in stomach cancer.

Authors:  H Nakatani; H Sakamoto; T Yoshida; J Yokota; E Tahara; T Sugimura; M Terada
Journal:  Jpn J Cancer Res       Date:  1990-08
View more
  6 in total

1.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

2.  Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer.

Authors:  Cheng-Wu Zhang; Shou-Chun Zou; Dun Shi; Da-Jian Zhao
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 3.  Extended lymphadenectomy in gastric cancer: when, for whom and why.

Authors:  D H Roukos
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

4.  Molecular epidemiology of gastric cancer: current status and future prospects.

Authors:  Zhibin Hu; Jaffer A Ajani; Qingyi Wei
Journal:  Gastrointest Cancer Res       Date:  2007-01

5.  Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.

Authors:  L P Setälä; V M Kosma; S Marin; P K Lipponen; M J Eskelinen; K J Syrjänen; E M Alhava
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

6.  Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma.

Authors:  H Nekarda; C Gess; M Stark; J D Mueller; U Fink; U Schenck; J R Siewert
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.